Navigation Links
Genetic Engineering & Biotechnology News reports on advances in miRNA
Date:2/29/2008

New Rochelle, NY, February 29, 2008 miRNA research is now one of the most interesting areas in the life science world, reports Genetic Engineering and Biotechnology News (GEN). Scientists around the globe are studying the effects of over- or underexpression of specific miRNAs on the development and inhibition of pathogenesis in a variety of diseases, according to an article titled miRNA-Regulated Pathways in the March 1 issue of GEN (http://www.genengnews.com/articles/chitem.aspx?aid=2382).

The appeal of miRNA technology lies in its promise and broad applicability across a wide spectrum of biotechnology and medical research, notes John Sterling, Editor-in-Chief of GEN. Increasing numbers of studies are focusing on conditions such as cancer, heart disease, and neurological disorders as well as on aging.

As more miRNAs are identified, researchers are correlating changes in miRNA levels with disease processes. For instance, scientists at the Wistar Institute recently identified miR-373 and miR-520c. Members of the same miRNA family, both were shown to promote tumor metastasis.

Also covered in the GEN article on miRNAs is research taking place at Asuragen, the University of Louisville, IBM, University of Texas Southwestern, Mira Therapeutics, and miRagen Therapeutics. In addition, GEN looks at the latest technologies and services from miRNA research enabling companies such as Exiqon, Sigma-Aldrich, Mirus Bio, Thermo Fisher Scientific, SuperArray Bioscience, and LC Sciences.


'/>"/>

Contact: John Sterling
jsterling@genengnews.com
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert

1

GOOD

Page: 1

Related biology news :

1. Does the desire to consume alcohol and tobacco come from our genetic makeup?
2. Diverse genetic abnormalities lead to NF-κB activation in multiple myeloma
3. Many parents at-risk for cancer disclose genetic test results to children
4. Genetics determine optimal drug dose of common anticoagulant
5. Claims of sex-related differences in genetic association studies often not properly validated
6. American College of Medical Genetics responds to new FDA labeling decision for warfarin
7. UNC study questions FDA genetic-screening guidelines for cancer drug
8. Genome study shines light on genetic link to height
9. Selexis Announces Advanced Approach to Maximize Power of Genetic Elements for Rapid Development of High Performance Cell Lines
10. Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring
11. Rutgers Genetics receives $7.8 million for autism research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...TON, La. A team of researchers at Louisiana Tech ...croorganism acts as a natural herbicide against gi...invasive aquatic weed that can block all sunlight ...ecosystems. Under ideal conditions, it,s been rep... three days. , Dr. H. Lynn Walker, professor of ...
(Date:11/19/2009)...LAFAYETTE, Ind. - Purdue University scientists hav...e responsible for cell wall development in maize, ...ays to produce the biomass best suited for biofuel...cholas Carpita, a professor of plant cell biology,...es in the journal Plant Physiology on Thursday (...
(Date:11/19/2009)...LLA, CA November 19, 2009 A team led by scientist...d a direct link between insulina hormone long asso...h as diabetesand core body temperature. While much...discovery in the 1920s, this is the first time the...cess of temperature regulation. , The paper was ...
Breaking Biology News(10 mins):Microorganism may provide key to combating giant salvinia throughout Louisiana 2Maize cell wall genes identified, giving boost to biofuel research 2Scripps research scientists find new link between insulin and core body temperature 2Scripps research scientists find new link between insulin and core body temperature 3Scripps research scientists find new link between insulin and core body temperature 4Women Speak Out Against Government Takeover of Health Care 54776 1Women Speak Out Against Government Takeover of Health Care 54776 2Women Speak Out Against Government Takeover of Health Care 54776 3Brooks Opens New Center for Back 26 Neck Health 54774 1Brooks Opens New Center for Back 26 Neck Health 54774 2Brooks Opens New Center for Back 26 Neck Health 54774 3MicroDynamics to Introduce New Microscope at Quality Expo 54772 1
...s M. D. Anderson Cancer Center say they have jumpe...nce (RNAi), believed by many to be the ultimate to... in the human genome and to treat disease. , Repo...igators have developed a simple way to use the RNA...c tissue in a mouse to determine the function of t...
...sity of Illinois atUrbana-Champaign has a home in ...f the swine genome to be completed with the help o...tment of Agriculture announced today (Jan. 13) by ...Schook, a professor of animal sciences at Illinois... Sequencing Consortium, will head the project that...
...esistant to antibiotics, causing problems for ther...at work in new kinds of ways. The last few years o... major difficulty for developers of antibiotics is...ria. There are hundreds of possible points of atta...lture experiments ?but validation in in vivo infec...
Other Biology News:Tool developed to silence genes in specific tissues using RNAi 2Tool developed to silence genes in specific tissues using RNAi 3Illinois pig to make history as source of first complete swine genome 2Salmonella caught red-handed 2
(Date:11/19/2009)...tria, November 19 AFFiRiS AG will ...ct candidate at an unexpectedly early,stage of dev... enter into,Phase II clinical trial early in 2010....the completion of two Phase I trials with the cand...ecision on the first interim,analysis of the secon...
(Date:11/18/2009)...to be able to find explosive materials and persons...earches, the National Institute of Standards and T... of Homeland Security, has developed a new certifi... (SRM) 2905, Trace Particulate Explosives. Compati...RM will be helpful in calibrating, testing and dev...
(Date:11/18/2009)...Nov. 18 Sangamo BioScien...ta from the University of Pennsylvania investigato... finger nuclease (ZFN) based product, SB-728-T, fo...losed on the internet. ,, Data were presented i...ia School of Medicine from a single subject treate...
(Date:11/18/2009)...t Sussex, U.K. and CLEVELAND, Nov. 18 /PRNewswire/...s business and premier provider of diagnostic syst...abs, has expanded its East Grinstead, U.K., manufa...eet increasing global demand for its Sensititre...tion testing. The expanded facility has been fully...
Breaking Biology Technology:AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3New NIST trace explosives standard slated for homeland security duty 2Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 3TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 4
...nce Inc. (NYSE:,CVD) today announced that it will ...ence on Tuesday, May 13, 2008 at 10:30 am ET. Inve...n at http://www.covance.com . In order to,registe...on 10 minutes,early., Covance, with headquarters ...rgest and most comprehensive drug development serv...
... USGI Medical, Inc. (USGI),the leader in incisionl...licensed its incisionless surgery technology to In... robotics applications. Financial terms of the dea...SGI,s technical and clinical development,including...president and,chief operating officer of Intuitive...
...Pharmaceuticals,Inc. (OTC Bulletin Board: NURX pre...ay 9th, the Company,s 1-for-4 reverse stock split ... the Over The Counter Bulletin,Board,s Corporate A...stock,split, its trading symbol has changed from N... the number of issued and,outstanding shares of Nu...
Other Biology Technology:USGI Medical Licenses Incisionless Surgery Technology to Intuitive Surgical 2USGI Medical Licenses Incisionless Surgery Technology to Intuitive Surgical 3NuRx Pharmaceuticals Announces Change of Ticker Symbol to NUXP, Reverse Stock Split Now in Effect 2
Rabbit Anti-Human Atrophin 1 Polyclonal Antibody, Unconjugated from Abcam
Anti-Bunyavirus (G1) Monoclonal Antibody, Unconjugated, Clone 8C2.1 from CHEMICON
Rabbit Anti-Complexin-1/2 (FL-134) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Mouse Anti-Human TP-1 Monoclonal Antibody, Unconjugated, Clone NDOG1 from Santa Cruz Biotechnology, Inc.
Biology Products: